A novel blood-based test for early detection of colorectal cancer in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC trial.
With high-sensitivity and strong negative predictive value, this artificial intelligence (AI)-powered tool enhances early colorectal cancer (CRC) detection and risk stratification in primary care.
Emily King of Mobile, Alabama, was diagnosed with colon cancer five years ago at the age of 27. She had experienced some diarrhea, abdominal pain and anemia, but having cancer had never entered ...
In New York, colorectal cancer is a top cause of cancer deaths across all populations. While screening rates have improved, they aren’t keeping pace with the rise in cases.
A colorectal cancer (CRC) screening public health initiative launched in Harbin, China has attracted about 830,000 participants for registration. The project utilizes fecal DNA methylation testing ...